Your session is about to expire
← Back to Search
Study Summary
This trial tests how a drug is absorbed, how it affects the body, and how safe and tolerable it is for healthy people in China and Japan.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You have had cancer in the past 10 years.You have taken AZD5055 before.You have a history of bone-related conditions like osteoporosis or fractures caused by weak bones.You have a history of severe allergies or ongoing allergies that are important for your health. Additionally, you have had allergic reactions to drugs similar to AZD5055.You smoke more than 20 cigarettes, e-cigarettes, or pipes per week.You are taking medications that can affect the way your body processes other drugs.You have a history of Gilbert's syndrome, a condition that affects the liver.You have a history of muscle disease or a condition called rhabdomyolysis.You have had a broken bone from an accident or injury in the past 6 months.You consume too much caffeine from drinks or food.You have a long-lasting infection or are more likely to get an infection.You have a history or current condition affecting your stomach, liver, kidneys, or any other condition that could affect how medications are processed in your body.You have had any significant illness, surgery, or injury within 4 weeks before starting the study.
- Group 1: AZD5055
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is AZD5055 a risk-free option for individuals?
"AZD5055 is a relatively novel medication, so the safety score was estimated at 1. This reflects that it's in its early clinical trial phase with only limited outcome data available."
Are there still vacancies available to participate in this trial?
"According to the info available on clinicaltrials.gov, this research initiative is no longer open for recruitment as of July 13th 2023. Nevertheless, there are still 798 other medical trials that currently require participants."
Is this research accommodating elderly participants over 85 years of age?
"This trial has a specified age range of 18 - 55, with 56 trials for minors and 372 specifically designed to meet the needs of elderly patients."
Am I eligible to enroll in this research trial?
"To be eligible to join this trial, potential participants should meet the criteria of being between 18-55 years and have healthy bodies. The total number of patients in the study is 40."
Share this study with friends
Copy Link
Messenger